Palivizumab is a man-made antibody to respiratory syncytial (sin-SISH-ul) virus (RSV). RSV can cause serious illness in children. Palivizumab helps keep RSV cells from multiplying in the body.

Palivizumab is used to prevent serious lung disease caused by respiratory syncytial virus in premature infants, and infants born with certain lung disorders or heart disease.

Palivizumab will not treat a child who is already sick with RSV disease.

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Average rating:  
 0 reviews
  • Synagis
  • More common
    Bluish color of the fingernails, lips, skin, palms, or nail beds
    blurred vision
    confusion
    cough
    difficulty with breathing
    difficulty with swallowing
    dizziness
    dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
    fast heartbeat
    fever
    hives or welts
    irregular, fast or slow, or shallow breathing
    itching
    large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
    loss of strength or energy
    muscle pain or weakness
    redness of the skin
    shortness of breath
    skin rash
    sweating
    tightness in the chest
    unresponsiveness
    unusual tiredness or weakness
    wheezing
    Incidence not known
    Black, tarry stools
    bleeding gums
    blood in the urine or stools
    pinpoint red spots on the skin
    unusual bleeding or bruising
    Some palivizumab side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

    Incidence not known
    Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
  • (intramuscular powder for injection, intramuscular solution)